05/01/2015 - 17:46 SAN FRANCISCO – Combining anti-CD38 monoclonal antibodies with standard antimyeloma therapies proved highly active without excessive toxicity in new... More » Visit websiteField of Interest: OncologyCategories: ONCR || NewsONCR || LeukemiaMyelodysplasiaTransplantationIMN || NewsIMN || OncologyAmerican Society of Hematology Annual MeetingNews Feed: Internal Medicine News - Oncology
